Search

everythinglearnresearchcommunity

for

Search:↓

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Deleting MED1 in skin cells causes hair loss and skin changes.

HDAC1 is crucial for skin development and preventing tumors.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Twist1 is crucial for UVB-induced skin cancer development.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.

Genetic variations in hair keratin proteins exist but don't significantly affect hair structure.

AP-1 controls tumor cell type by affecting key signaling pathways.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

ALKBH5 helps wounds heal faster by stabilizing PELI2 mRNA.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Alkaline Ceramidase 1 prevents early hair loss in mice by keeping hair follicle stem cells balanced.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Involucrin is a useful marker for keratinocyte differentiation in mice.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.